These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29659675)

  • 1. Facing the Inevitable: Being Prepared for Regulatory Requirements for Laboratory Developed Tests.
    D'Angelo R; Weiss R; Wolfe D; Chinnam R; Murat A; Gluesing J; Somers T
    Am J Clin Pathol; 2018 Apr; 149(6):484-498. PubMed ID: 29659675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance.
    Sidawy MK
    Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383
    [No Abstract]   [Full Text] [Related]  

  • 3. Laboratory-Developed Tests: A Legislative and Regulatory Review.
    Genzen JR; Mohlman JS; Lynch JL; Squires MW; Weiss RL
    Clin Chem; 2017 Oct; 63(10):1575-1584. PubMed ID: 28687634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Laboratory-Developed Tests.
    Genzen JR
    Am J Clin Pathol; 2019 Jul; 152(2):122-131. PubMed ID: 31242284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-developed test regulation and the immunocompromised patient: uncertainty ahead.
    Clark AE; Levy J; Lee FM
    Curr Opin Infect Dis; 2020 Aug; 33(4):304-311. PubMed ID: 32657967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan.
    Tazawa Y
    Breast Cancer; 2016 Jan; 23(1):19-23. PubMed ID: 25605056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostics Reform and Harmonization of Clinical Laboratory Testing.
    Schreier J; Feeney R; Keeling P
    J Mol Diagn; 2019 Sep; 21(5):737-745. PubMed ID: 31075512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ideas and Briefing about Regulatory Requirements for Laboratory Developed Tests in the US].
    Han Z; Zhao Y; L Y; Dong J; Deng G
    Zhongguo Yi Liao Qi Xie Za Zhi; 2022 Sep; 46(5):534-537. PubMed ID: 36254482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-Counterpoint: The FDA Has a Role in Regulation of Laboratory-Developed Tests.
    Caliendo AM; Hanson KE
    J Clin Microbiol; 2016 Apr; 54(4):829-33. PubMed ID: 26791369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA's draft guidance on laboratory-developed tests increases clinical and economic risk to adoption of pharmacogenetic testing.
    Levy KD; Pratt VM; Skaar TC; Vance GH; Flockhart DA
    J Clin Pharmacol; 2015 Jul; 55(7):725-7. PubMed ID: 26053647
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA oversight of laboratory-developed tests will facilitate adoption of pharmacogenetic testing into routine clinical care.
    Hillebrenner E; Litwack E; Bradley P; Donigan K; Lowe T; Serrano K; Kelm K; Mansfield E; Gutierrez A
    J Clin Pharmacol; 2015 Jul; 55(7):728-30. PubMed ID: 26053648
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory-Developed Tests: Design of a Regulatory Strategy in Compliance with the International State-of-the-Art and the Regulation (EU) 2017/746 (EU IVDR [In Vitro Diagnostic Medical Device Regulation]).
    Spitzenberger F; Patel J; Gebuhr I; Kruttwig K; Safi A; Meisel C
    Ther Innov Regul Sci; 2022 Jan; 56(1):47-64. PubMed ID: 34291407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long and winding regulatory road for laboratory-developed tests.
    Weiss RL
    Am J Clin Pathol; 2012 Jul; 138(1):20-6. PubMed ID: 22706853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory-developed tests are not the practice of medicine.
    Allen JS
    MLO Med Lab Obs; 2015 Sep; 47(9):46. PubMed ID: 26495599
    [No Abstract]   [Full Text] [Related]  

  • 15. LDTs and the FDA: The saga continues.
    Longwell A
    MLO Med Lab Obs; 2017 Apr; 49(4):40, 43. PubMed ID: 29979012
    [No Abstract]   [Full Text] [Related]  

  • 16. Good laboratory practices for molecular genetic testing for heritable diseases and conditions.
    Chen B; Gagnon M; Shahangian S; Anderson NL; Howerton DA; Boone JD;
    MMWR Recomm Rep; 2009 Jun; 58(RR-6):1-37; quiz CE-1-4. PubMed ID: 19521335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A call for participatory oversight.
    Terry SF
    Genet Test Mol Biomarkers; 2014 Feb; 18(2):71-2. PubMed ID: 24506510
    [No Abstract]   [Full Text] [Related]  

  • 18. FDA's framework for regulatory oversight of LDTs.
    Pathak B; Terry SF
    Genet Test Mol Biomarkers; 2014 Dec; 18(12):785-6. PubMed ID: 25469801
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines for the order process of medical laboratory tests].
    Annaix V; Drouillard I; Palette X; Serre-Debeauvais F; Szymanowicz A; Yvert JP;
    Ann Biol Clin (Paris); 2010 Dec; 68 Spec No 1():43-67. PubMed ID: 21613007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FDA's proposed rule for the regulation of laboratory-developed tests.
    Miller MB; Watts ML; Samuel L
    J Clin Microbiol; 2024 Feb; 62(2):e0148823. PubMed ID: 38206042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.